Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 7354673, 7 pages
https://doi.org/10.1155/2017/7354673
Clinical Study

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves’ Disease

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
2Graduate School, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
3Chaum Life Center, CHA University School of Medicine, Seoul 06062, Republic of Korea
4Division of Endocrinology, Department of Internal Medicine, Inseong Hallym Hospital, Incheon 21079, Republic of Korea

Correspondence should be addressed to Dong Yeob Shin; ca.shuy@iygnodnihs

Received 25 June 2017; Revised 10 October 2017; Accepted 18 October 2017; Published 5 December 2017

Academic Editor: Jack Wall

Copyright © 2017 Se Hee Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Brent, “Clinical practice. Graves’ disease,” The New England Journal of Medicine, vol. 358, pp. 2594–2605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Weetman, “Graves’ disease,” The New England Journal of Medicine, vol. 343, pp. 1236–1248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Vanderpump, W. M. Tunbridge, J. M. French et al., “The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey,” Clinical Endocrinology, vol. 43, no. 1, pp. 55–68, 1995. View at Publisher · View at Google Scholar
  4. H. B. Burch and L. Wartofsky, “Life-threatening thyrotoxicosis. Thyroid storm,” Endocrinology and Metabolism Clinics of North America, vol. 22, pp. 263–277, 1993. View at Google Scholar
  5. O. Torring, L. Tallstedt, G. Wallin et al., “Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid study group,” The Journal of Clinical Endocrinology & Metabolism, vol. 81, pp. 2986–2993, 1996. View at Publisher · View at Google Scholar
  6. L. Wartofsky, D. Glinoer, B. Solomon et al., “Differences and similarities in the diagnosis and treatment of Graves’ disease in Europe, Japan, and the United States,” Thyroid, vol. 1, no. 2, pp. 129–135, 1991. View at Publisher · View at Google Scholar
  7. D. S. Ross, “Radioiodine therapy for hyperthyroidism,” The New England Journal of Medicine, vol. 364, pp. 542–550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Peters, C. Fischer, U. Bogner, C. Reiners, and H. Schleusener, “Radioiodine therapy of Graves’ hyperthyroidism: standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study,” European Journal of Clinical Investigation, vol. 25, pp. 186–193, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. A. E. Jarlov, L. Hegedus, L. O. Kristensen, B. Nygaard, and J. M. Hansen, “Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?” Clinical Endocrinology, vol. 43, pp. 325–329, 1995. View at Publisher · View at Google Scholar
  10. A. Collier, S. Ghosh, M. Hair, I. Malik, and J. McGarvie, “Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves? Disease,” Hormones, vol. 8, pp. 273–278, 2009. View at Publisher · View at Google Scholar
  11. M. A. Walter, M. Christ-Crain, B. Eckard et al., “Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome,” European Journal of Clinical Investigation, vol. 34, no. 5, pp. 365–370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. E. K. Alexander and P. R. Larsen, “High dose 131I therapy for the treatment of hyperthyroidism caused by Graves disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, pp. 1073–1077, 2002. View at Publisher · View at Google Scholar
  13. A. Berghout, W. M. Wiersinga, N. J. Smits, and J. L. Touber, “Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area,” Clinical Endocrinology, vol. 26, pp. 273–280, 1987. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Şeker and İ. Taş, “Determination of thyroid volume and its relation with isthmus thickness,” European Journal of General Medicine, vol. 7, no. 2, 2010. View at Google Scholar
  15. D. Ueda, “Normal volume of the thyroid gland in children,” Journal of Clinical Ultrasound, vol. 18, pp. 455–462, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Rago, L. Chiovato, L. Grasso, A. Pinchera, and P. Vitti, “Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects,” Journal of Endocrinological Investigation, vol. 24, pp. 763–769, 2001. View at Publisher · View at Google Scholar
  17. A. Moura-Neto, C. Mosci, A. O. Santos et al., “Predictive factors of failure in a fixed 15 mCi 131I-iodide therapy for Graves’ disease,” Clinical Nuclear Medicine, vol. 37, no. 6, pp. 550–554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. de Jong, H. M. Verkooijen, G. D. Valk, P. M. Zelissen, and B. de Keizer, “High failure rates after 131I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover,” Clinical Nuclear Medicine, vol. 38, pp. 401–406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Aktay, K. Rezai, J. E. Seabold, R. S. Bar, and P. T. Kirchner, “Four- to twenty-four-hour uptake ratio: an index of rapid iodine-131 turnover in hyperthyroidism,” Journal of Nuclear Medicine, vol. 37, pp. 1815–1819, 1996. View at Google Scholar
  20. J. W. van Isselt and H. S. Broekhuizen-de Gast, “The radioiodine turnover rate as a determinant of radioiodine treatment outcome in Graves’ disease,” Hellenic Journal of Nuclear Medicine, vol. 13, pp. 2–5, 2010. View at Google Scholar
  21. A. W. Goolden and T. R. Fraser, “Treatment of thyrotoxicosis with low doses of radioactive iodine,” British Medical Journal, vol. 3, pp. 442-443, 1969. View at Publisher · View at Google Scholar · View at Scopus
  22. G. H. Seo, S. W. Kim, and J. H. Chung, “Incidence & prevalence of hyperthyroidism and preference for therapeutic modalities in Korea,” Journal of Korean Thyroid Association, vol. 6, pp. 56–63, 2013. View at Publisher · View at Google Scholar